Profile data is unavailable for this security.
About the company
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. Its TriKE platform generates therapeutics designed to harness and enhance the cancer killing abilities of a patient’s own natural killer (NK) cells. The Company is also using its TriKE platform to develop therapeutics useful for the treatment of infectious disease such as for the treatment of patients infected by the human immunodeficiency virus (HIV). Its GTB-3550 is the first-generation TriKE product candidate which was a single-chain, tri-specific recombinant fusion protein construct composed of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15, all connected by small peptide linkers.
- Revenue in USD (TTM)0.00
- Net income in USD-11.35m
- Incorporated1973
- Employees2.00
- LocationGT Biopharma Inc315 MONTGOMERY STREET, 10TH FLOORSAN FRANCISCO 94104United StatesUSA
- Phone+1 (310) 551-4020
- Fax+1 (302) 655-5049
- Websitehttps://www.gtbiopharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sentient Brands Holdings Inc | 0.00 | -954.07k | 3.73m | 2.00 | -- | -- | -- | -- | -0.0164 | -0.0164 | 0.00 | -0.0307 | 0.00 | 0.00 | -- | 0.00 | -460.67 | -220.36 | -- | -- | -- | 41.81 | -- | -31,451.19 | 0.0015 | -2.50 | -- | -- | -73.68 | -- | 34.98 | -- | -- | -- |
Aoxing Pharmaceutical Company Inc | 30.11m | -1.46m | 3.92m | 339.00 | -- | 0.0459 | -- | 0.1303 | -0.0192 | -0.0192 | 0.3951 | 0.2507 | 0.496 | 2.32 | 2.56 | -- | -2.41 | -14.54 | -7.06 | -35.45 | 76.19 | 68.51 | -4.85 | -37.69 | 0.7368 | 0.3387 | 0.6052 | -- | 26.88 | 37.20 | -62.49 | -- | -38.80 | -- |
Evoke Pharma Inc | 7.53m | -6.53m | 3.95m | 4.00 | -- | 1.48 | -- | 0.5253 | -16.23 | -16.23 | 11.24 | 3.63 | 0.7128 | 0.4307 | 4.97 | 1,881,428.00 | -61.83 | -100.48 | -136.53 | -151.10 | 96.97 | -- | -86.75 | -480.52 | 1.22 | -19.91 | 0.6523 | -- | 106.51 | -- | 5.25 | -- | -- | -- |
Processa Pharmaceuticals Inc | 0.00 | -10.22m | 4.04m | 13.00 | -- | 0.5906 | -- | -- | -5.36 | -5.36 | 0.00 | 2.10 | 0.00 | -- | -- | 0.00 | -115.58 | -84.35 | -133.48 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0016 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 4.24m | -- | 0.0236 | 0.0051 | 1.16 | 0.3981 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
Guardion Health Sciences Inc | 6.43m | -5.93m | 4.39m | 9.00 | -- | 0.3035 | -- | 0.6826 | -4.61 | 4.97 | 5.04 | 10.71 | 0.4467 | 2.74 | 8.20 | 714,121.10 | -41.22 | -77.90 | -45.86 | -86.55 | 44.86 | 42.45 | -92.26 | -176.93 | 16.59 | -2.98 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
AgriFORCE Growing Systems Ltd | 57.60k | -15.05m | 4.53m | 7.00 | -- | 0.3575 | -- | 78.62 | -5.81 | -5.81 | 0.0037 | 0.1343 | 0.0034 | -- | 1.21 | 8,228.57 | -88.79 | -78.95 | -124.14 | -109.86 | 17.86 | -- | -26,121.49 | -243,182.50 | 1.24 | -1.28 | 0.0789 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
Titan Pharmaceuticals Inc | 4.00k | -5.46m | 4.60m | 4.00 | -- | 1.15 | -- | 1,149.65 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
GT Biopharma Inc | 0.00 | -11.35m | 4.61m | 2.00 | -- | 0.8378 | -- | -- | -7.72 | -7.72 | 0.00 | 2.47 | 0.00 | -- | -- | 0.00 | -82.84 | -205.36 | -120.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
China Pharma Holdings Inc | 6.25m | -4.40m | 4.63m | 231.00 | -- | 0.625 | -- | 0.7411 | -0.6254 | -0.6254 | 0.6379 | 0.4317 | 0.417 | 2.34 | 23.57 | 27,047.32 | -29.39 | -29.66 | -59.89 | -55.25 | -25.89 | 6.47 | -70.48 | -73.09 | 0.2449 | -21.22 | 0.3494 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
Silo Pharma Inc | 72.12k | -3.45m | 4.71m | 3.00 | -- | 0.6558 | -- | 65.29 | -1.16 | -1.18 | 0.0242 | 1.60 | 0.0079 | -- | -- | 24,040.00 | -37.69 | -24.90 | -43.50 | -26.39 | 91.90 | 82.79 | -4,777.02 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
Stemtech Corp | 5.37m | -5.11m | 4.76m | 45.00 | -- | -- | -- | 0.8867 | -0.0518 | -0.0518 | 0.0529 | -0.0359 | 1.33 | 8.39 | 42.31 | -- | -126.26 | -- | -- | -- | 77.87 | -- | -95.16 | -- | 0.065 | -2.59 | -- | -- | 7.94 | -- | 36.45 | -- | -- | -- |
Biofrontera Inc | 35.24m | -13.51m | 4.82m | 85.00 | -- | 0.4057 | -- | 0.1367 | -5.29 | -5.29 | 12.12 | 2.14 | 1.21 | 1.97 | 7.27 | 414,623.50 | -46.20 | -- | -113.24 | -- | 47.75 | -- | -38.33 | -- | 1.46 | -3.53 | 0.0264 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
Universe Pharmaceuticals Inc | 26.73m | -18.55m | 5.07m | 225.00 | -- | 0.0292 | -- | 0.1897 | -5.10 | -5.10 | 7.35 | 7.34 | 0.4462 | 6.13 | 1.68 | 118,781.90 | -30.97 | 5.31 | -48.85 | 7.07 | 28.27 | 46.26 | -69.40 | 6.25 | 1.46 | -0.6939 | 0.1958 | 0.00 | -19.52 | 2.53 | 29.46 | -- | -21.17 | -- |
CYANOTECH CORP | 23.82m | -5.10m | 5.08m | 77.00 | -- | 0.4758 | -- | 0.2133 | -0.7549 | -0.7549 | 3.56 | 1.53 | 0.8895 | 2.05 | 12.12 | 309,389.60 | -19.04 | -3.46 | -29.60 | -4.46 | 24.72 | 34.54 | -21.41 | -3.58 | 0.3354 | -6.61 | 0.377 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
Holder | Shares | % Held |
---|---|---|
Deka Investment GmbHas of 30 Jun 2024 | 978.36k | 45.37% |
Bristol Capital Advisors LLCas of 23 May 2024 | 190.00k | 8.81% |
Armistice Capital LLCas of 26 Apr 2024 | 72.51k | 3.36% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 20.51k | 0.95% |
BMO Asset Management Corp.as of 31 Mar 2024 | 19.87k | 0.92% |
Geode Capital Management LLCas of 30 Jun 2024 | 11.18k | 0.52% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 10.13k | 0.47% |
Wells Fargo Advisors Financial Network LLCas of 31 Mar 2024 | 10.01k | 0.46% |
Tower Research Capital LLCas of 31 Mar 2024 | 2.30k | 0.11% |
UBS Securities LLCas of 31 Mar 2024 | 1.02k | 0.05% |